Nanotechnology against the novel coronavirus (severe acute respiratory syndrome coronavirus 2): diagnosis, treatment, therapy and future perspectives
The emergence of COVID-19 has affected millions of people around the world and has become a serious threat to human life. To date, nanotechnology-based tools have been effective in preclinical studies against a variety of pathogens, including respiratory viruses, herpes virus, human papillomavirus and HIV. Nanoparticles, particles smaller than a micrometer, have drawn particular interest in the management of COVID-19 disease due to their unique properties (easy preparation, low cost, easy modification, appropriate size, etc). Nanotechnology-based strategies for COVID-19 disease management include the development of tools for rapid, accurate and sensitive diagnosis, production of effective disinfectants, delivery of mRNA vaccines into human cells and delivery of antiviral agents into the body.
This review summarizes all of the exciting advances nanomaterials are making toward COVID-19 prevention, diagnosis and therapy.View the full article Go to Journal Content page